Furthermore, considering that altered DNA replication is a significant characteristic of various cancers such as lung, liver, and gastric cancers and that therapeutic regimens targeting DNA replication proteins like CDC6 and RPA1 have demonstrated a significant slowdown effect on the progression of LUAD. Here, RPA1 is linked to gastric cancer.